The fact that the label allows for Kadcyla as front-line single agent therapy is HUGE. This FDA greenlight was really not expected until next year. Not only is the survival outcome significantly better, there is no hair loss or nausea. It's a fundamental advance over chemotherapy. I'm just kidding about Oprah, but there is no question this will get major media coverage as the ramifications for women become understood.